Sang‐Yull Lee

867 total citations
28 papers, 684 citations indexed

About

Sang‐Yull Lee is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sang‐Yull Lee has authored 28 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Immunology and 5 papers in Oncology. Recurrent topics in Sang‐Yull Lee's work include Immunotherapy and Immune Responses (18 papers), RNA Interference and Gene Delivery (13 papers) and vaccines and immunoinformatics approaches (5 papers). Sang‐Yull Lee is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), RNA Interference and Gene Delivery (13 papers) and vaccines and immunoinformatics approaches (5 papers). Sang‐Yull Lee collaborates with scholars based in South Korea, United States and Russia. Sang‐Yull Lee's co-authors include Lloyd J. Old, Achim A. Jungbluth, Matthew J. Scanlan, Elisabeth Stockert, Barbara Williamson, Yao‐Tseng Chen, Chang Hun Lee, Dong‐Hoon Shin, Min Ki Lee and Yeong‐Min Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sang‐Yull Lee

27 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sang‐Yull Lee South Korea 16 411 351 176 85 67 28 684
Ioannis F. Voutsas Greece 16 305 0.7× 510 1.5× 305 1.7× 93 1.1× 58 0.9× 36 812
Hweixian Leong Penny United States 9 265 0.6× 381 1.1× 259 1.5× 67 0.8× 23 0.3× 11 604
Kevin A. Myers United Kingdom 17 460 1.1× 335 1.0× 357 2.0× 90 1.1× 50 0.7× 28 925
Martina Di Modica Italy 12 588 1.4× 249 0.7× 444 2.5× 47 0.6× 90 1.3× 15 972
Ian Daniels United Kingdom 15 204 0.5× 255 0.7× 130 0.7× 37 0.4× 24 0.4× 35 544
Inmaculada Rioja United Kingdom 21 643 1.6× 267 0.8× 157 0.9× 34 0.4× 32 0.5× 39 1.1k
Tsung‐Chieh Shih Taiwan 15 508 1.2× 179 0.5× 102 0.6× 34 0.4× 46 0.7× 20 725
Anna Rossini Italy 12 514 1.3× 276 0.8× 217 1.2× 37 0.4× 76 1.1× 22 940
Brigitte Kahn‐Perlès France 17 404 1.0× 358 1.0× 132 0.8× 119 1.4× 16 0.2× 32 822

Countries citing papers authored by Sang‐Yull Lee

Since Specialization
Citations

This map shows the geographic impact of Sang‐Yull Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Yull Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Yull Lee more than expected).

Fields of papers citing papers by Sang‐Yull Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Yull Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Yull Lee. The network helps show where Sang‐Yull Lee may publish in the future.

Co-authorship network of co-authors of Sang‐Yull Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Yull Lee. A scholar is included among the top collaborators of Sang‐Yull Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Yull Lee. Sang‐Yull Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Jae Heun, Hojung Choi, Yong Jung Kang, et al.. (2022). MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer. Experimental Hematology and Oncology. 11(1). 68–68. 5 indexed citations
2.
Kim, Young Mi, Jaehoon Jung, Tae-Hyung Kim, et al.. (2019). Anti-oxidant and Anti-inflammatory Effects of Aquatic Exercise in Allergic Airway Inflammation in Mice. Frontiers in Physiology. 10. 1227–1227. 12 indexed citations
3.
Bae, Jae‐Ho, et al.. (2017). A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells. Biochemical and Biophysical Research Communications. 484(2). 298–303. 4 indexed citations
4.
Lee, Junwon, et al.. (2017). Identification of tumor antigens in malignant mesothelioma. Oncology Letters. 14(4). 4557–4562. 2 indexed citations
5.
Yin, Wenjie, Dorothée Duluc, Yaming Xue, et al.. (2016). Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity. Cancer Immunology Research. 4(10). 823–834. 25 indexed citations
6.
Bae, Jae‐Ho, et al.. (2016). Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells. Oncology Letters. 13(2). 784–790. 3 indexed citations
7.
Lee, Junwon, et al.. (2015). Cancer/testis antigen NY-SAR-35 enhances cell proliferation, migration, and invasion. International Journal of Oncology. 48(2). 569–576. 6 indexed citations
8.
Choi, Kyung Un, et al.. (2012). Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma. Oncology Reports. 28(5). 1792–1798. 23 indexed citations
9.
Miliotto, Anthony, et al.. (2012). A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation. International Journal of Oncology. 41(3). 1139–1147. 8 indexed citations
10.
Shin, Dong‐Hoon, et al.. (2012). KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer. International Journal of Oncology. 41(5). 1820–1826. 15 indexed citations
11.
Kim, Yeong Dae, et al.. (2012). Pattern of cancer/testis antigen expression in lung cancer patients. International Journal of Molecular Medicine. 29(4). 656–662. 30 indexed citations
12.
Park, Jin-Hyung, et al.. (2011). Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation. Biotechnology Letters. 33(6). 1085–1091. 9 indexed citations
13.
Hwang, Sang‐Hyun, Ki Uk Kim, Ji‐Eun Kim, et al.. (2011). Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clinical Chemistry and Laboratory Medicine (CCLM). 49(4). 699–704. 47 indexed citations
14.
Lee, Sang Mok, et al.. (2011). Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX. Biochemical and Biophysical Research Communications. 408(2). 195–201. 30 indexed citations
15.
16.
Jeong, Young-Il, In Duk Jung, Chang-Min Lee, et al.. (2009). The Novel Role of Platelet-Activating Factor in Protecting Mice against Lipopolysaccharide-Induced Endotoxic Shock. PLoS ONE. 4(8). e6503–e6503. 40 indexed citations
17.
Kim, Sang‐Hyun, Sang‐Yull Lee, Chang Hun Lee, et al.. (2009). Expression of Cancer-Testis Antigens MAGE-A3/6 and NY-ESO-1 in Non-Small-Cell Lung Carcinomas and Their Relationship with Immune Cell Infiltration. Lung. 187(6). 401–411. 59 indexed citations
18.
Lee, Jun Sik, In Duk Jung, Young-Il Jeong, et al.. (2007). d-pinitol inhibits Th1 polarization via the suppression of dendritic cells. International Immunopharmacology. 7(6). 791–804. 31 indexed citations
19.
20.
Scanlan, Matthew J., Claudia Gordon, Barbara Williamson, et al.. (2002). Identification of cancer/testis genes by database mining and mRNA expression analysis. International Journal of Cancer. 98(4). 485–492. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis F. Voutsas Breakdown of academic impact, for papers by Hweixian Leong Penny Breakdown of academic impact, for papers by Kevin A. Myers Breakdown of academic impact, for papers by Martina Di Modica Breakdown of academic impact, for papers by Ian Daniels Breakdown of academic impact, for papers by Inmaculada Rioja Breakdown of academic impact, for papers by Tsung‐Chieh Shih Breakdown of academic impact, for papers by Anna Rossini Breakdown of academic impact, for papers by Brigitte Kahn‐Perlès
Rankless by CCL
2026